Boston Scientific Forecast, price target & analysts
Boston Scientific Target price 2026 - Analyst rating & recommendation
Boston Scientific Classifications & Recommendation
Boston Scientific Price Target
| Target Price | $61.20 |
| Price | $43.72 |
| Potential |
39.98%
register free of charge
|
| Number of Estimates | 33 |
|
33 Analysts have issued a price target Boston Scientific 2027 .
The average Boston Scientific target price is $61.20.
This is
39.98%
register free of charge
$123.90
183.39%
register free of charge
$44.44
1.65%
register free of charge
|
|
| A rating was issued by 38 analysts: 30 Analysts recommend Boston Scientific to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Boston Scientific stock has an average upside potential 2027 of
39.98%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 20.07 | 21.51 |
| 19.87% | 7.14% | |
| EBITDA Margin | 24.39% | 30.80% |
| 4.41% | 26.26% | |
| Net Margin | 14.44% | 22.44% |
| 30.47% | 55.44% |
34 Analysts have issued a sales forecast Boston Scientific 2026 . The average Boston Scientific sales estimate is
This results in the following potential growth metrics:
24 Analysts have issued an Boston Scientific EBITDA forecast 2026. The average Boston Scientific EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
35 Boston Scientific Analysts have issued a net profit forecast 2026. The average Boston Scientific net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.94 | 3.34 |
| 55.20% | 72.16% | |
| P/E | 13.11 | |
| EV/Sales | 3.51 |
35 Analysts have issued a Boston Scientific forecast for earnings per share. The average Boston Scientific EPS is
This results in the following potential growth metrics and future valuations:
Boston Scientific...
Current Boston Scientific Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citigroup |
Locked
➜
Locked
|
Locked | Sep 17 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 25 2026 |
| Argus Research |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Citigroup:
Locked
➜
Locked
|
Sep 17 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 25 2026 |
|
Locked
Argus Research:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Jul 30 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
